CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company
Oncotelic Therapeutics, Inc.
Sign in to watch- Ticker
- OTLC
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 133679168
- Phone
- 650-635-7000
- Business address
- 29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
- Former names
- MATEON THERAPEUTICS INC, OXIGENE INC
- 4 Open-market buy CHAIRMAN AND CEO bought 500,000 shares at an average $0.02 ($10,875)
- 4 Open-market buy CHAIRMAN AND CEO bought 100,000 shares at $0.03 ($2,600)
- 4 Open-market buy CHAIRMAN AND CEO bought 400,000 shares at $0.03 ($13,040)
- 4 Open-market buy CHAIRMAN AND CEO bought 126,888 shares at $0.03 ($4,327)
- 10-Q Report Quarterly Report
- 8-K Event Bylaws or fiscal year change
- NT 10-Q Other NT 10-Q
- 424B3 Offering Prospectus
- 4 Open-market buy CHAIRMAN AND CEO bought 100,000 shares at $0.05 ($4,500)
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K/A Report 10-K/A
- POS AM Other Post-effective Amendment for Registration Statement
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market buy CHAIRMAN AND CEO bought 120,000 shares at $0.05 ($6,000)
Page 5 of 61 · 1,218 filings